PortfoliosLab logo
BIIB vs. UNH
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between BIIB and UNH is 0.40, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.0
Correlation: 0.4

Performance

BIIB vs. UNH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Biogen Inc. (BIIB) and UnitedHealth Group Incorporated (UNH). The values are adjusted to include any dividend payments, if applicable.

0.00%10,000.00%20,000.00%30,000.00%40,000.00%50,000.00%December2025FebruaryMarchAprilMay
3,852.96%
32,885.81%
BIIB
UNH

Key characteristics

Sharpe Ratio

BIIB:

-1.53

UNH:

-0.43

Sortino Ratio

BIIB:

-2.29

UNH:

-0.32

Omega Ratio

BIIB:

0.74

UNH:

0.94

Calmar Ratio

BIIB:

-0.56

UNH:

-0.45

Martin Ratio

BIIB:

-1.45

UNH:

-1.26

Ulcer Index

BIIB:

29.33%

UNH:

12.73%

Daily Std Dev

BIIB:

27.82%

UNH:

37.40%

Max Drawdown

BIIB:

-90.00%

UNH:

-82.68%

Current Drawdown

BIIB:

-74.05%

UNH:

-35.52%

Fundamentals

Market Cap

BIIB:

$17.72B

UNH:

$364.71B

EPS

BIIB:

$11.18

UNH:

$23.90

PE Ratio

BIIB:

10.82

UNH:

16.76

PEG Ratio

BIIB:

6.24

UNH:

0.88

PS Ratio

BIIB:

1.81

UNH:

0.89

PB Ratio

BIIB:

1.04

UNH:

3.71

Total Revenue (TTM)

BIIB:

$9.70B

UNH:

$407.42B

Gross Profit (TTM)

BIIB:

$7.73B

UNH:

$87.53B

EBITDA (TTM)

BIIB:

$1.61B

UNH:

$31.08B

Returns By Period

In the year-to-date period, BIIB achieves a -19.22% return, which is significantly higher than UNH's -20.60% return. Over the past 10 years, BIIB has underperformed UNH with an annualized return of -10.79%, while UNH has yielded a comparatively higher 15.22% annualized return.


BIIB

YTD

-19.22%

1M

-5.93%

6M

-28.92%

1Y

-42.14%

5Y*

-15.90%

10Y*

-10.79%

UNH

YTD

-20.60%

1M

-23.56%

6M

-28.96%

1Y

-17.58%

5Y*

8.65%

10Y*

15.22%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

BIIB vs. UNH — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BIIB
The Risk-Adjusted Performance Rank of BIIB is 66
Overall Rank
The Sharpe Ratio Rank of BIIB is 00
Sharpe Ratio Rank
The Sortino Ratio Rank of BIIB is 11
Sortino Ratio Rank
The Omega Ratio Rank of BIIB is 33
Omega Ratio Rank
The Calmar Ratio Rank of BIIB is 1717
Calmar Ratio Rank
The Martin Ratio Rank of BIIB is 99
Martin Ratio Rank

UNH
The Risk-Adjusted Performance Rank of UNH is 2525
Overall Rank
The Sharpe Ratio Rank of UNH is 2828
Sharpe Ratio Rank
The Sortino Ratio Rank of UNH is 2828
Sortino Ratio Rank
The Omega Ratio Rank of UNH is 2626
Omega Ratio Rank
The Calmar Ratio Rank of UNH is 2323
Calmar Ratio Rank
The Martin Ratio Rank of UNH is 1717
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

BIIB vs. UNH - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Biogen Inc. (BIIB) and UnitedHealth Group Incorporated (UNH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for BIIB, currently valued at -1.53, compared to the broader market-2.00-1.000.001.002.003.00
BIIB: -1.53
UNH: -0.43
The chart of Sortino ratio for BIIB, currently valued at -2.29, compared to the broader market-6.00-4.00-2.000.002.004.00
BIIB: -2.29
UNH: -0.32
The chart of Omega ratio for BIIB, currently valued at 0.74, compared to the broader market0.501.001.502.00
BIIB: 0.74
UNH: 0.94
The chart of Calmar ratio for BIIB, currently valued at -0.56, compared to the broader market0.001.002.003.004.005.00
BIIB: -0.56
UNH: -0.45
The chart of Martin ratio for BIIB, currently valued at -1.45, compared to the broader market-40.00-30.00-20.00-10.000.0010.0020.00
BIIB: -1.45
UNH: -1.26

The current BIIB Sharpe Ratio is -1.53, which is lower than the UNH Sharpe Ratio of -0.43. The chart below compares the historical Sharpe Ratios of BIIB and UNH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.50-1.00-0.500.000.501.00December2025FebruaryMarchAprilMay
-1.53
-0.43
BIIB
UNH

Dividends

BIIB vs. UNH - Dividend Comparison

BIIB has not paid dividends to shareholders, while UNH's dividend yield for the trailing twelve months is around 2.10%.


TTM20242023202220212020201920182017201620152014
BIIB
Biogen Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
UNH
UnitedHealth Group Incorporated
2.10%1.62%1.38%1.21%1.12%1.38%1.41%1.38%1.30%1.48%1.59%1.39%

Drawdowns

BIIB vs. UNH - Drawdown Comparison

The maximum BIIB drawdown since its inception was -90.00%, which is greater than UNH's maximum drawdown of -82.68%. Use the drawdown chart below to compare losses from any high point for BIIB and UNH. For additional features, visit the drawdowns tool.


-80.00%-60.00%-40.00%-20.00%0.00%December2025FebruaryMarchAprilMay
-74.05%
-35.52%
BIIB
UNH

Volatility

BIIB vs. UNH - Volatility Comparison

The current volatility for Biogen Inc. (BIIB) is 13.59%, while UnitedHealth Group Incorporated (UNH) has a volatility of 28.00%. This indicates that BIIB experiences smaller price fluctuations and is considered to be less risky than UNH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%25.00%30.00%December2025FebruaryMarchAprilMay
13.59%
28.00%
BIIB
UNH

Financials

BIIB vs. UNH - Financials Comparison

This section allows you to compare key financial metrics between Biogen Inc. and UnitedHealth Group Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00B40.00B60.00B80.00B100.00B20212022202320242025
2.43B
109.58B
(BIIB) Total Revenue
(UNH) Total Revenue
Values in USD except per share items

BIIB vs. UNH - Profitability Comparison

The chart below illustrates the profitability comparison between Biogen Inc. and UnitedHealth Group Incorporated over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%40.0%60.0%80.0%100.0%20212022202320242025
74.1%
21.7%
(BIIB) Gross Margin
(UNH) Gross Margin
BIIB - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Biogen Inc. reported a gross profit of 1.80B and revenue of 2.43B. Therefore, the gross margin over that period was 74.1%.
UNH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, UnitedHealth Group Incorporated reported a gross profit of 23.77B and revenue of 109.58B. Therefore, the gross margin over that period was 21.7%.
BIIB - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Biogen Inc. reported an operating income of 625.20M and revenue of 2.43B, resulting in an operating margin of 25.7%.
UNH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, UnitedHealth Group Incorporated reported an operating income of 9.12B and revenue of 109.58B, resulting in an operating margin of 8.3%.
BIIB - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Biogen Inc. reported a net income of 240.50M and revenue of 2.43B, resulting in a net margin of 9.9%.
UNH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, UnitedHealth Group Incorporated reported a net income of 6.29B and revenue of 109.58B, resulting in a net margin of 5.7%.